Estrogen Metabolism: Does the Formation of Estrogen Quinone Provide a Potential Pathway to Breast Carcinogenesis?

  • Cyrus R. Creveling
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)


Estrogen has long been implicated in the initiation of carcinogenesis in estrogen-sensitive tissues through receptor-mediated events (Girder and Brotherick, 2000). However recent studies indicate that estrogens may cause DNA damage directly and independent of receptor-mediated mechanisms through the oxidation products of estrogen metabolism. The major pathway for estrogen metabolism proceeds by two steps: First the aromatic hydroxylation of the primary estrogens to form 2- and 4-hydroxycatechol estrogens. Under normal conditions these catechols rapidly undergo O-methylation, catalyzed by catechol-O-methyltransferase (COMT). The evidence for the rapid O-methylation is several fold. While virtually all catechols are substrates for COMT the highest affinities for the enzyme are exhibited by the catechol estrogens (Ball and Knuppen, 1985). Further the O-methylated products are the major urinary estrogen metabolites. Importantly, the efficiency of the O-methylation pathway is reflected in the extremely short half-life of catechol estrogens (Lipsett et. al. 1983).


COMT Gene Estrogen Metabolism Catechol Estrogen Japanese Diet Apurinic Site 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adlercreutz, H., Honjo, H., Higashi, A. Fotsis, E., Hamalainen, E., Hasegawa, T., and Okada, H., 1991, Urinary-excretion of lignanas and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet., American Journal of clinical Nutrition 54, (6), 1093–1100.PubMedGoogle Scholar
  2. Ball, P., and Knuppen, R. 1985 Catecholestrogens (2- and 4-hydroxyestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol. Suppl (Copenh) 232, 1–127.Google Scholar
  3. Balu, N., Li, E-M, Rogan, E., and Cavalieri, E. 1999 A unifying mechanism in the reaction of catechol-,catecholamines- and catecholestrogen quinones with nucleophilic sites in DNA. Proc. American Assoc. Cancer Res. 40, 46.Google Scholar
  4. Cavalieri, E., and Rogan, E., 2000, The key role of catecholestrogen-3, 4-quinones in tumor initiation, in: Role of Catechol Quinone Species in Cellular Toxicity, C. R. Creveling, ed., F. P. Graham Publishing, Johnson City, TN pp 247–260.Google Scholar
  5. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., Roy, D. 2000 Estrogens as endogenous genotoxic agents—DNA adducts and mutations, Journal of the National Cancer Institute USA, , 27, 75–93.CrossRefGoogle Scholar
  6. Creveling, C R. and Inoue, K, 1995 Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone Drug Metabolism and Disposition 23, 430–432.PubMedGoogle Scholar
  7. Creveling, C. R. 1994 Catechol-O-methyltransferase: Role in Estrogen-Induced Carcinogenesis. “Dietary Phytoestrogens: Cancer Cause of Prevention?” National Cancer Institute, Division of Cancer Etiology, Chemical and Physical Carcinogenesis Branch, The Hyatt Dulles Hotel at Washington Dulles International Airport, Herndon VA. September 21–23.Google Scholar
  8. Davis, S.R., Dalsis, F. S., and Simpson, E.R. 1999 Phytoestrogens in Health and Disease, Recent Progress in Hormone Research 54, 185–211.PubMedGoogle Scholar
  9. Garner, K E., Burka, L. I., Etheridge, A. E., and Matthews, H., B. 2000 Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens. Toxicology and Applied Pharmacology 162, 115–123.PubMedCrossRefGoogle Scholar
  10. Garner, C E., Matthews, H.B., and Burka, L.T. 1999 Phenolphthalein metabolites inhibit catechol-O-methyltransferased-mediates metabolism of catechol estrogens: a possible mechanism for carcinogenicity. (2000) Toxicology and Applied Pharmacology 162, 124–131CrossRefGoogle Scholar
  11. Girdler, F., and Brotheric, I. 2000 The oestrogen receptors and their role in breast cancer: a review. The Breast 9, 194–200.PubMedCrossRefGoogle Scholar
  12. Huang, C S., Chern, H.D, Chang, K.J. Hsu, S.M., and Shen, C.Y. 1999 Breast cancer risk associated with genotype polymorphism of the estrogen metabolizing enzymes genes CYP17, CYP1A1, and COMT. Cancer Researh 59, 4870–4875.Google Scholar
  13. Inoue, M., Tajima, K., Mizutani, M., 2001 Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital based Epidemiologic Research Program at Aichi Cancer Center(HERPACC) Japan. Cancer Letter 167, 175–182.CrossRefGoogle Scholar
  14. Isemura, M., Saeki, K., and Kimura, T. (2000) Tea catechins and related polyphenols as anti-cancer agents. Biofactors 13, 81–85.PubMedCrossRefGoogle Scholar
  15. Jefcoate, C. R., Liehr, J. G., Santan, R.J., Sutter, T. R., Yager, J. D., Wei, Y., Santner, S. J., Tekmal, R., Demers, L., Pauley, R., Naftolin, F., Mor, G., and Berstein, L. 2000 Tissue-specific synthesis and oxidative metabolism of estrogens. J National Cancer Institute, monograph 27, 95–112.CrossRefGoogle Scholar
  16. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strictland P. E., Bell D. A., Selmin O. An association between the allele coding for a low activity varient of catechol-O-methyltransferase and the risk of breast cancer 1997, Cancer Research 57, 5493–5497.PubMedGoogle Scholar
  17. Lipsett, M., Merriam G., Kono, S. Brandon, D., Pheiffer, D., Loriaux, D. Metabolic clearance of catecholestrogens in: Catechol Estrogens, Merriam, G. R. and Lipsett, M. D., eds. Raven Press, New York, pp 105–114, 1983.Google Scholar
  18. Malins, D.C., Polissar, NX., Nishikida, K., Holmes, E.H., Gardner, H.S., and Gunselman S.J. 1995 The etiology and prediction of breast cancer. Fourier transform-infrared spectroscopy reveals progressive alteration in breast DNA leading to a cancer-like phenotype in a high proportion of normal women (1995) Cancer 75, 503–517.PubMedCrossRefGoogle Scholar
  19. Smit, N. P. M., and Pavel, S. 1995 Induction of cytotoxicity in melanoma cells through inhibition of catechol- O-methyltransferase Biochemical Pharmacology 50, 1955–1962.PubMedCrossRefGoogle Scholar
  20. Thompson, P. A., Shields, P. G., Freudenheim J. L., Stone A., Vena J. E., Marshall J. R., 1998, Genetic polymorphisms in Catechol-O-methyl transferase, menopausal status and breast cancer risk. Cancer Research, 58, 2107–2110.PubMedGoogle Scholar
  21. Vidgren J., Svenson, L. A., and Lijas, A. 1994, Crystal structure of catechol-O-methyltransferase 1994, Nature 368, 354–358.PubMedCrossRefGoogle Scholar
  22. Weisz, J., Fritz-Wolz, G., Gesti, S., Clawson, G. A., Creveling, C. R., Liehr, J. G., and Dabbs, D., 2000, Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells, American Journal of Pathology, 156, 1841–1848.PubMedCrossRefGoogle Scholar
  23. Zhu B. T., and Liehr, J. G., 1996, Inhibition of catechol-O-methyltransferase-catalyzed O-methylation of 2-and 4-hydroxyestradiol by quercetin, Journal of Biological Chemistry. 271, 149–159.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Cyrus R. Creveling
    • 1
  1. 1.National Institute of Diabetes and Digestive and Kidney DiseasesNational Institutes of HealthBethesdaUSA

Personalised recommendations